Renal clearable catalytic gold nanoclusters for in vivo disease monitoring
NIHR Imperial Biomedical Research Centre · Imperial College London · +6 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
506
total citations
- FWCI
- 23.49
- Percentile
- 100%
- References
- 52
Citations per year
Authors
9- CNColleen N. LoynachanCorresponding
NIHR Imperial Biomedical Research Centre, Imperial College London
- APAva P. Soleimany
Harvard University, Harvard–MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology
- JSJaideep S. Dudani
Massachusetts Institute of Technology
- YLYiyang Lin
NIHR Imperial Biomedical Research Centre, Imperial College London
- ANAdrian Najer
NIHR Imperial Biomedical Research Centre, Imperial College London
Topics & keywords
Topics
Keywords
- Nanoclusters
- In vivo
- Nanosensor
- Nanotechnology
- Materials science
- Nanomedicine
- Chemistry
- Nanoparticle
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.
Funding
- NSNational Science FoundationAward: P30-CA14051
- FCFrancis Crick Institute
- MAMarshall Aid Commemoration Commission
- KIKoch Institute for Integrative Cancer Research, Massachusetts Institute of TechnologyAwards: P30-CA14051, Grant P30-CA14051
- ICImperial College London
- NINational Institutes of HealthAwards: GM008313, NIH/NIGMS T32 GM008313, ES002109, NIGMS T32 GM008313, P30-CA14051, T32 GM008313, P30-ES002109
- EAEngineering and Physical Sciences Research CouncilAwards: EP/K031953/1, EP/K031953/1
- NCNational Cancer InstituteAwards: P30-ES002109, Koch Institute Support Grant P30-CA14051, P30-CA14051, CA14051, Grant P30-CA14051
- NINational Institute of General Medical SciencesAwards: GM008313, NIH/NIGMS T32 GM008313, NIGMS T32 GM008313, T32 GM008313
- NINational Institute of Environmental Health SciencesAwards: ES002109, Grant P30-ES002109, P30-ES002109